ALMR
Alamar Biosciences, Inc.
34.40$
+5.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | |
| 51.2% | 46.9% | 44.5% | 39.8% | |
| 48.8% | 53.1% | 55.5% | 60.2% | |
| 63.4% | 55.0% | 50.0% | 47.0% | |
| 50.7% | 47.1% | 53.0% | 59.2% | |
| 165.3% | 149.0% | 103.0% | 106.2% | |
| -65.3% | -49.0% | -47.4% | -46.0% | |
| 0.4% | 0.3% | 0.9% | 0.8% | |
| -58.5% | -43.5% | -80.1% | -45.2% | |
| – | – | 1.8% | -0.3% | |
| -58.5% | -43.5% | -81.9% | -44.9% | |
| -51.4% | -37.5% | -74.8% | -44.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.